Alshimary, N. A. A. H. and Tweij, T.-A. R. (2025) “Praliciguat alleviates ferroptosis and inflammation in renal ischemia/reperfusion injury by targeting the AMPK/ACC/PUFA pathway”, Babcock University Medical Journal, 8(2), pp. 198–207. doi: 10.38029/babcockuniv.med.j. v8i2.992.